课题基金 / 基金详情

项目摘要

项目成果

KEITH A. REIMANN的其他基金

相似基金

相关文献

中文摘要
翻译
非人灵长类动物作为动物模型在翻译研究中起着至关重要的作用 为探讨传染病和非传染性疾病的发病机制,并测试 生物疗法和疫苗。当许多人类诊断免疫试剂交叉 与翻译研究中常用的灵长类物种反应,存在差距 相当数量的试剂靶标。此外,针对特定免疫系统的抗体 体内特定淋巴细胞亚群的功能或耗尽已被证明在 定义疾病机制或可用作新疗法的概念验证。 在过去的15年里,NIH非人灵长类试剂资源对 通过开发、制造和分销NHP来满足科学界的需求- 体外诊断和体内使用的特殊试剂。这一资源的利用具有 自从这个项目开始以来,它的增长速度非常快。在上一个预算年度,我们履行了 来自126名调查人员的500份试剂请求,并分发了超过300克的重组 用于给药的NHP抗体。 利用抗体方面的科学进步和技术进步 开发、工程、表达和矢量化,我们将继续支持 科学界利用所有科学学科的NHP模型。
英文摘要
Nonhuman primates (NHPs) serve a crucial role in translational research as animal models for exploring the pathogenesis of infectious and noninfectious diseases, and for testing of biologic therapies and vaccines. While many human diagnostic immunologic reagents cross react with the primate species commonly employed in translational research, gaps exist for a substantial number of reagent targets. Furthermore, antibodies that target specific immune functions or deplete specific lymphocyte subpopulations in vivo have proven valuable in defining disease mechanisms or can be used as proof-of-concept for new therapies. For the past 15 years, the NIH Nonhuman Primate Reagent Resource has responded to needs of the scientific community by developing, manufacturing and distributing NHP- specific reagents for in vitro diagnostics and for in vivo use. Utilization of this resource has grown dramatically since this program's inception. During the last budget year, we fulfilled 500 reagent requests from 126 investigators and distributed over 300 grams of recombinant antibody for administration to NHPs. Taking advantage of scientific advances and technological improvements in antibody development, engineering, expression and vectoring, we will continue to support the scientific community utilizing NHP models across all scientific disciplines.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
NHP reagent resource for AIDS HIV research
NHP reagent resource for immune-mediated and infectious diseases, and transplantation research
RESOURCE FOR NONHUMAN PRIMATE CELL-DEPLETING ANTIBODIES
  • 批准号:
    8357921
  • 项目类别:
  • 资助金额:
    $6.84万
  • 财政年份:
    2011
  • 负责人:
    KEITH A. REIMANN
  • 依托单位:
RESOURCE FOR NONHUMAN PRIMATE CELL-DEPLETING ANTIBODIES
  • 批准号:
    8172826
  • 项目类别:
  • 资助金额:
    $6.58万
  • 财政年份:
    2010
  • 负责人:
    KEITH A. REIMANN
  • 依托单位:
海外基金